Drs. Siefker-Radtke, Koshkin on the NORSE Study for Metastatic Urothelial Carcinoma

By Arlene O. Siefker-Radtke, MD, Vadim Koshkin, MD - Last Updated: June 15, 2023

Arlene O. Siefker-Radtke, MD, The University of Texas MD Anderson Cancer Center, and Vadim Koshkin, MD, University of California, San Francisco, detail the phase 2 NORSE study design, results, and implications for treating patients with metastatic urothelial carcinoma and FGFR alterations.

View more ASCO 2023 videos.

Advertisement
Advertisement